Salma Amin
About
In The Last Decade
Salma Amin
22 papers receiving 588 citations
Peers
Comparison fields: 5 of 74
- Oncology 316
- Endocrinology, Diabetes and Metabolism 180
- Surgery 158
- Molecular Biology 140
- Immunology 111
Countries citing papers authored by Salma Amin
This map shows the geographic impact of Salma Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salma Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salma Amin more than expected).
Fields of papers citing papers by Salma Amin
This network shows the impact of papers produced by Salma Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salma Amin. The network helps show where Salma Amin may publish in the future.
Co-authorship network of co-authors of Salma Amin
This figure shows the co-authorship network connecting the top 25 collaborators of Salma Amin. A scholar is included among the top collaborators of Salma Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salma Amin. Salma Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 32 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 87 | |
| 11 | 16 | |
| 12 | 16 | |
| 13 | 81 | |
| 14 | 45 | |
| 15 | 23 | |
| 16 | 1 | |
| 17 | 21 | |
| 18 | Vaccine-induced apoptosis: a novel clinical trial end point? | 25 |
| 19 | A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55. | 45 |
| 20 | 32 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.